A2 Milk sinks 11% as FDA defers new approvals
Subscribe to BusinessDesk
Stay informed on business, government and financial developments across New Zealand.
- Deeply researched, twice-edited and fact-checked news
- Annual subscribers also receive a complimentary subscription to The Wall Street Journal
- Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers
You can cancel anytime with two clicks, an email or a phone call.
Find out more.
We are serious about journalism.
Already a Subscriber ? Sign in here.
All subscriptions auto renew but are easy to cancel.
Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}
Not convinced yet?
Subscribe to our free 7am Headlines newsletter.
A quick summary of everything BusinessDesk has published in the previous 24 hours. No BusinessDesk
subscription needed.
Employment data dominates quiet day on NZ sharemarket
The NZ sharemarket was down with no real trend driving the change.
‘Remarkable growth’: Fulton Hogan posts higher profit
Fulton Hogan paid a total dividend of $180.4m for 2025.
Seymour promotes coal, nuclear, and privatisation
Burning some coal to enable more renewable power "not a bad deal".
Health insurance proving a valuable negotiating tool for Kiwi businesses
More employers see health insurance as key to staff wellbeing.
Move-in ready offices: How business are rethinking workspace
Businesses want agility – and office space is evolving fast
